Luke T Lavallée

14PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Haematological tumoursEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 27, 2026
Outcomes and Predictors of Recurrence and Survival in Surgically Resected Localized Chromophobe Renal Cell Carcinoma: Results from the Canadian Kidney Cancer Information System (CKCis).

Erica Arenovich, Rodney Breau, Ricardo Rendon

|Aug 22, 2025
Incidence of Local Treatment and Metastasis During Active Surveillance for Patients With a Small Renal Mass in a National Multicenter Prospective Cohort.

Luke T Lavallée, Antonio Finelli, Simon Tanguay

|Jun 27, 2025
Prostate cancer detection by MRI-ultrasonography fusion transperineal vs transrectal biopsy: a randomised control trial.

Nicola Schieda, Christopher Morash, Luke T Lavallee

|Dec 04, 2024
Is there a minimum percentage of sarcomatoid component required to affect outcomes of localised renal cell carcinoma?

Mustafa Soytas, Alice Dragomir, Ghady Bou-Nehme Sawaya

|Jul 04, 2024
Thromboprophylaxis during neoadjuvant chemotherapy for bladder cancer reduces thromboembolism and bleeding.

Luca Antonelli, Pedro David Wendel-Garcia, Manja Deforth

|Jul 06, 2023
Estimated glomerular filtration rate from the renal hypothermia trial: clinical implications.

Francis Lemire, Dean A Fergusson, Greg Knoll

Pageof 3

Frequent Collaborators

4 joint publications

Rodney H Breau

2 joint publications

Simon Tanguay

2 joint publications

Nicola Schieda

2 joint publications

Rahul Bansal